by The U.S. over the counter (OTC) drugs market size was estimated to be around US$ 23.03 billion in 2023 and is projected to reach US$ 41.72 billion by 2033, indicating a CAGR of 6.42% from 2024 to 2033.
Key Points
- By product type, the cough & cold products segment held the largest share of the market in 2023, the segment is observed to witness a notable growth during the forecast period.
- By dosage form, the tablets segment dominated the market with the largest share in 2023.
- By route of administration, the oral segment held the largest share of the market and is expected to sustain the position throughout the forecast period.
- By distribution channel, the drug stores & retail pharmacies segment dominated the U.S. over the counter (OTC) drugs market in 2023.
The market research report on the U.S. over the counter (OTC) drugs market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of U.S. over the counter (OTC) drugs products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3753
U.S. Over the Counter (OTC) Drugs Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.42% |
| U.S. Market Size in 2023 | USD 23.03 Billion |
| U.S. Market Size by 2033 | USD 41.72 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product Type, By Dosage Form, By Route of Administration, and By Distribution Channel |
Read More: Artificial Intelligence Engineering Market Size, Growth Report by 2033
The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global U.S. over the counter (OTC) drugs market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the U.S. over the counter (OTC) drugs market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of U.S. over the counter (OTC) drugs products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the U.S. over the counter (OTC) drugs market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the U.S. over the counter (OTC) drugs market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Key Market Players
- Bayer AG
- Takeda Pharmaceutical Company Ltd.
- Pfizer
- Johnson & Johnson Services Inc.
- Sanofi S.A.
- Novartis AG
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Mylan
- UPM Pharmaceuticals
Segments Covered in the Report
By Product Type
- Vitamin and Dietary Supplements
- Cough & Cold Products
- Analgesics
- Gastrointestinal Products
- Sleep Aids
- Otic Products
- Wart Removers
- Mouth Care Products
- Ophthalmic Products
- Botanicals
- Antacids
- Smoking Cessation Products
- Feminine Care
- Others
By Dosage Form
- Tablets
- Hard Capsules
- Powders
- Ointments
- Soft Capsules
- Liquids
- Others
By Route of Administration
- Oral
- Parenteral
- Topical
- Others
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Over the Counter (OTC) Drugs Market
5.1. COVID-19 Landscape: U.S. Over the Counter (OTC) Drugs Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Over the Counter (OTC) Drugs Market, By Product Type
8.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Product Type, 2024-2033
8.1.1. Vitamin and Dietary Supplements
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Cough & Cold Products
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Analgesics
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Gastrointestinal Products
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Sleep Aids
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Otic Products
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Wart Removers
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Mouth Care Products
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
8.1.9. Ophthalmic Products
8.1.9.1. Market Revenue and Volume Forecast (2021-2033)
8.1.10. Botanicals
8.1.10.1. Market Revenue and Volume Forecast (2021-2033)
8.1.11. Antacids
8.1.11.1. Market Revenue and Volume Forecast (2021-2033)
8.1.12. Smoking Cessation Products
8.1.12.1. Market Revenue and Volume Forecast (2021-2033)
8.1.13. Feminine Care
8.1.13.1. Market Revenue and Volume Forecast (2021-2033)
8.1.14. Others
8.1.14.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. U.S. Over the Counter (OTC) Drugs Market, By Dosage Form
9.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Dosage Form, 2024-2033
9.1.1. Tablets
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Hard Capsules
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Powders
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Ointments
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Soft Capsules
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
9.1.6. Liquids
9.1.6.1. Market Revenue and Volume Forecast (2021-2033)
9.1.7. Others
9.1.7.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. U.S. Over the Counter (OTC) Drugs Market, By Route of Administration
10.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Route of Administration, 2024-2033
10.1.1. Oral
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Parenteral
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Topical
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. U.S. Over the Counter (OTC) Drugs Market, By Distribution Channel
11.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Distribution Channel, 2024-2033
11.1.1. Drug Stores & Retail Pharmacies
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Hospital Pharmacies
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Online Pharmacies
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. U.S. Over the Counter (OTC) Drugs Market and Trend Forecast
12.1. U.S.
12.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Dosage Form (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
Chapter 13. Company Profiles
13.1. Bayer AG
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Takeda Pharmaceutical Company Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Pfizer
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Johnson & Johnson Services Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sanofi S.A.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Novartis AG
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Boehringer Ingelheim International GmbH
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. GlaxoSmithKline PLC
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Mylan
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. UPM Pharmaceuticals
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
